Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhoujun Shen

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cancer Biology & Therapy|May 31, 2011
Targeting the inflammatory pathways to enhance chemotherapy of cancerZhaowei Zhu, Shan Zhong, Zhoujun Shen
Zhonghua Nan Ke Xue = National Journal of Andrology|April 15, 2004
[Malignant fibrous histiocytoma of the prostate: one case report]Zhoujun Shen, Hua Wang, Shanwen Chen
Mediators of Inflammation|July 20, 2012
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancerZhaowei Zhu, Zhoujun Shen, Chen Xu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Targeted therapy for advanced urothelial cancer of the bladder: where do we stand?Zhaowei Zhu, Zhoujun Shen, Chen Xu
Urology|April 21, 2009
Effects of steroid hormones on morphology and vascular endothelial growth factor expression in female bladderYanlan Yu, Zhoujun Shen, Xielai Zhou, et al.
Urology|August 17, 2010
Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapiesMinguang Zhang, Ran Tao, Cunming Zhang, et al.
Urologia Internationalis|March 8, 2013
Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large seriesXiaohua Zhang, Zhaowei Zhu, Tianyuan Xu, et al.
Diabetes Research and Clinical Practice|June 19, 2012
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysisZhaowei Zhu, Zhoujun Shen, Yingli Lu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 11, 2015
Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytomaXiaohua Zhang, Xianjin Wang, Tianyuan Xu, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|February 26, 2004
[Erectile function evaluation after adult circumcision]Zhoujun Shen, Shanwen Chen, Chunxia Zhu, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cancer Biology & Therapy|May 31, 2011
Targeting the inflammatory pathways to enhance chemotherapy of cancerZhaowei Zhu, Shan Zhong, Zhoujun Shen
Zhonghua Nan Ke Xue = National Journal of Andrology|April 15, 2004
[Malignant fibrous histiocytoma of the prostate: one case report]Zhoujun Shen, Hua Wang, Shanwen Chen
Mediators of Inflammation|July 20, 2012
Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancerZhaowei Zhu, Zhoujun Shen, Chen Xu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Targeted therapy for advanced urothelial cancer of the bladder: where do we stand?Zhaowei Zhu, Zhoujun Shen, Chen Xu
Urology|April 21, 2009
Effects of steroid hormones on morphology and vascular endothelial growth factor expression in female bladderYanlan Yu, Zhoujun Shen, Xielai Zhou, et al.
Urology|August 17, 2010
Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapiesMinguang Zhang, Ran Tao, Cunming Zhang, et al.
Urologia Internationalis|March 8, 2013
Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large seriesXiaohua Zhang, Zhaowei Zhu, Tianyuan Xu, et al.
Diabetes Research and Clinical Practice|June 19, 2012
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysisZhaowei Zhu, Zhoujun Shen, Yingli Lu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 11, 2015
Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytomaXiaohua Zhang, Xianjin Wang, Tianyuan Xu, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|February 26, 2004
[Erectile function evaluation after adult circumcision]Zhoujun Shen, Shanwen Chen, Chunxia Zhu, et al.
Pageof 7